231 related articles for article (PubMed ID: 19794112)
1. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.
Wang Y; Wang DH
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112
[TBL] [Abstract][Full Text] [Related]
2. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
[TBL] [Abstract][Full Text] [Related]
3. Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension.
Wang Y; Babánková D; Huang J; Swain GM; Wang DH
Hypertension; 2008 Aug; 52(2):264-70. PubMed ID: 18606907
[TBL] [Abstract][Full Text] [Related]
4. [Role of transient receptor potential vanilloid type 1 and C-C chemokine receptor 2 in renal injury induced by salt-sensitive hype].
Zhu FY; Liu WH; Wang XX; Cui L; Shen S; Zhu MJ; Wang YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):488-95. PubMed ID: 25360645
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
Wang Y; Wang DH
Mol Med; 2011; 17(11-12):1204-12. PubMed ID: 21792478
[TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.
Manhiani M; Quigley JE; Knight SF; Tasoobshirazi S; Moore T; Brands MW; Hammock BD; Imig JD
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F740-8. PubMed ID: 19553349
[TBL] [Abstract][Full Text] [Related]
7. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y
Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.
Elmarakby AA; Quigley JE; Imig JD; Pollock JS; Pollock DM
Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R76-83. PubMed ID: 17989143
[TBL] [Abstract][Full Text] [Related]
9. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
Lyu B; Wang W; Ji XY; Ritter JK; Li N
BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187
[TBL] [Abstract][Full Text] [Related]
10. Role of substance P in renal injury during DOCA-salt hypertension.
Wang Y; Wang DH
Endocrinology; 2012 Dec; 153(12):5972-9. PubMed ID: 23024265
[TBL] [Abstract][Full Text] [Related]
11. Role of the transient receptor potential vanilloid type 1 channel in renal inflammation induced by lipopolysaccharide in mice.
Wang Y; Wang DH
Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R1-9. PubMed ID: 23152109
[TBL] [Abstract][Full Text] [Related]
12. Renal Inflammation in DOCA-Salt Hypertension.
Banek CT; Gauthier MM; Van Helden DA; Fink GD; Osborn JW
Hypertension; 2019 May; 73(5):1079-1086. PubMed ID: 30879356
[TBL] [Abstract][Full Text] [Related]
13. IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice.
Thomas JM; Ling YH; Huuskes B; Jelinic M; Sharma P; Saini N; Ferens DM; Diep H; Krishnan SM; Kemp-Harper BK; O'Connor PM; Latz E; Arumugam TV; Guzik TJ; Hickey MJ; Mansell A; Sobey CG; Vinh A; Drummond GR
Hypertension; 2021 Nov; 78(5):1296-1309. PubMed ID: 34488433
[TBL] [Abstract][Full Text] [Related]
14. Tumor Necrosis Factor Alpha Deficiency Improves Endothelial Function and Cardiovascular Injury in Deoxycorticosterone Acetate/Salt-Hypertensive Mice.
Cai R; Hao Y; Liu YY; Huang L; Yao Y; Zhou MS
Biomed Res Int; 2020; 2020():3921074. PubMed ID: 32190663
[TBL] [Abstract][Full Text] [Related]
15. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
[TBL] [Abstract][Full Text] [Related]
16. TRPV1 signaling of perirenal adipose tissue promotes DOCA-Salt-induced hypertension and kidney injury.
Hua D; Huang W; Huang W; Xie Q; Tang L; Wu X; Gao M; Xu T; Zhang Y; Li P; Sun W; Kong X
J Hypertens; 2024 Aug; 42(8):1409-1420. PubMed ID: 38690943
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism.
Weng HC; Lu XY; Xu YP; Wang YH; Wang D; Feng YL; Chi Z; Yan XQ; Lu CS; Wang HW
Mol Med; 2021 Nov; 27(1):147. PubMed ID: 34773993
[TBL] [Abstract][Full Text] [Related]
18. Role of calcitonin gene-related peptide in hypertension-induced renal damage.
Bowers MC; Katki KA; Rao A; Koehler M; Patel P; Spiekerman A; DiPette DJ; Supowit SC
Hypertension; 2005 Jul; 46(1):51-7. PubMed ID: 15928032
[TBL] [Abstract][Full Text] [Related]
19. Ablation of TRPV1-positive nerves exacerbates salt-induced hypertension and tissue injury in rats after renal ischemia-reperfusion via infiltration of macrophages.
Yu SQ; Ma S; Wang DH
Clin Exp Hypertens; 2021 Apr; 43(3):254-262. PubMed ID: 33327798
[No Abstract] [Full Text] [Related]
20. TRPV1 ablation aggravates inflammatory responses and organ damage during endotoxic shock.
Wang Y; Wang DH
Clin Vaccine Immunol; 2013 Jul; 20(7):1008-15. PubMed ID: 23637043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
